Aclaris Therapeutics, Inc. (ACRS)

CIK 1557746 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aclaris Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001104659-26-123374
Nov 5, 20268-K0001104659-26-123039
Oct 27, 2026424B50001104659-26-119223
Oct 27, 20268-K0001104659-26-118952
Oct 27, 20268-K0001104659-26-119231
Sep 21, 2026SCHEDULE 13G0001231919-26-001199
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000915
Aug 6, 20268-K0001104659-26-091629
Aug 6, 20268-K0001104659-26-092128
Aug 6, 2026S-3ASR0001104659-26-092113
Aug 6, 202610-Q0001104659-26-092065
Aug 4, 202640002076327-26-000006
Jun 8, 202640001280044-26-000004
Jun 8, 202640001674278-26-000002
Jun 8, 202640001187159-26-000002
Jun 8, 202640001590102-26-000002
Jun 8, 202640001172252-26-000002
Jun 8, 202640001654773-26-000003
Jun 4, 20268-K0001104659-26-070494
May 12, 2026SCHEDULE 13G/A0001213900-26-055376
May 7, 20268-K0001104659-26-056669
May 7, 202610-Q0001104659-26-057202
May 5, 202640002065269-26-000004
Apr 28, 20268-K0001104659-26-049733
Apr 27, 202640001373604-26-000034